Cite
HARVARD Citation
Lescuyer, S. et al. (2019). Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera. International journal of infectious diseases. pp. 134-136. [Online].